The report provides an all-inclusive analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/10661
Rise in prevalence of neurological disorders, increase in geriatric population, and technological advancements in neurodiagnostics drive the growth of the global neurodiagnostics market. On the other hand, stringent government regulations impede the growth to some extent. However, high market growth potential in the developing countries has been beneficial for the market growth.
COVID-19 scenario-
Rise in the focus of clinics & hospitals in setting up COVID-19 specific intensive care units (ICUs) along with temporary deferment of neuro-diagnostics devices production and manufacturing sites in the affected regions impacted the global neurodiagnostics market negatively.
However, the global situation is being ameliorated at a gradual pace, and the market is expected to recoup soon.
The global neurodiagnostics market is analyzed across product, condition, end user, and region. By product, the diagnostic & imaging systems segment accounted for more than three-fifths of the total market revenue in 2020, and is anticipated to lead the trail by the end of 2030. Simultaneously, the In vitro diagnostics segment would cite the fastest CAGR of 7.8% throughout the forecast period.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/10661
By condition, the neuro degenerative diseases segment contributed to around two-fifths of the total market share in 2020, and is expected to rule the roost till 2030. The segment is also expected to register the fastest CAGR of 8.0% during the study period.
By geography, North America generated the major share in 2020, holding more than two-fifths of the global market. Moreover, Asia-Pacific would cite the fastest CAGR of 8.6% by 2030. The other provinces analyzed through the market report include Europe and LAMEA.
The key market players analyzed in the global neurodiagnostics market report include Canon, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, QIAGEN N.V., Lifelines Neuro Company, LLC, Philips Co., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., and Siemens AG. These market players have implemented several strategies including partnership, expansion, collaboration, joint ventures, and others to heighten their status in the industry.
